RespireRx Pharmaceuticals Inc. CEO Issues Progress and Status Report

NEXT STORY
Beroni Group Featured in New Research Initiation Report
PREV STORY
Generex Biotechnology Announces Investor Conference Dial-In Details Addressing the Coronavirus Pandemic with Ii-Key Peptide Vaccines and Corporate Update Thursday February 13, 2020 at 11:00 AM EST
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ascendis Pharma A/S Announces Filing of the Clinical Trial Notification for Phase 3 Clinical Trial of TransCon™ hGH for Pediatric Growth Hormone Deficiency in Japan

author_avatar
NASDAQ Market News

Forty Seven, Inc. and Ono Pharmaceutical Co., Ltd. Sign Regional License Agreement to Develop, Manufacture and Commercialize 5F9 in Japan, South Korea, Taiwan and Select Countries in Southeast Asia

author_avatar
NASDAQ Market News

TESARO Joins OCRFA as Presenting Sponsor of the 2017 Ovarian Cancer National Conference

WALTHAM, Mass., June 29, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

author_avatar
NASDAQ Market News